| Inhibition of IL-6/STAT3 axis and targeting Axl and Tyro3 receptor tyrosine kinases by apigenin circumvent taxol resistance in ovarian cancer cells YA Suh, SY Jo, HY Lee, C Lee International journal of oncology 46 (3), 1405-1411, 2015 | 110 | 2015 |
| MicroRNA‐320a and microRNA‐4496 attenuate Helicobacter pylori cytotoxin‐associated gene A (CagA)‐induced cancer‐initiating potential and chemoresistance … DW Kang, ES Yang, YN Noh, WC Hwang, SY Jo, YA Suh, WS Park, ... The Journal of pathology 241 (5), 614-625, 2017 | 24 | 2017 |
| PPARγ sumoylation-mediated lipid accumulation in lung cancer ANH Phan, VTA Vo, TNM Hua, MK Kim, SY Jo, JW Choi, HW Kim, J Son, ... Oncotarget 8 (47), 82491, 2017 | 22 | 2017 |
| Impact of mouse contamination in genomic profiling of patient-derived models and best practice for robust analysis SY Jo, E Kim, S Kim Genome biology 20, 1-13, 2019 | 20 | 2019 |
| Inhibition of never in mitosis A (NIMA)-related kinase-4 reduces survivin expression and sensitizes cancer cells to TRAIL-induced cell death SJ Park, DS Jo, SY Jo, DW Shin, S Shim, YK Jo, JH Shin, YJ Ha, ... Oncotarget 7 (40), 65957, 2016 | 16 | 2016 |
| Suppression of gain-of-function mutant p53 with metabolic inhibitors reduces tumor growth in vivo CL Jung, H Mun, SY Jo, JH Oh, CH Lee, EK Choi, SJ Jang, YA Suh Oncotarget 7 (47), 77664, 2016 | 10 | 2016 |
| Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer HS Lee, E Kim, J Lee, SJ Park, HK Hwang, CH Park, SY Jo, CM Kang, ... EBioMedicine 65, 2021 | 6 | 2021 |
| Comprehensive benchmarking and guidelines of mosaic variant calling strategies YJ Ha, S Kang, J Kim, J Kim, SY Jo, S Kim Nature Methods 20 (12), 2058-2067, 2023 | 5 | 2023 |
| Genomic and transcriptomic profiling reveal molecular characteristics of parathyroid carcinoma SY Jo, N Hong, S Lee, JJ Jeong, J Won, J Park, GJ Kim, SK Kim, S Kim, ... Experimental & Molecular Medicine 55 (5), 886-897, 2023 | 2 | 2023 |
| Transcriptional immune suppression and up-regulation of double-stranded DNA damage and repair repertoires in ecDNA-containing tumors MS Lin, SY Jo, J Luebeck, HY Chang, S Wu, PS Mischel, V Bafna eLife 12, RP88895, 2024 | 1 | 2024 |
| Taxotere induces dephosphorylation of MET in patient-derived tumor models H Mun, SH Lee, CH Lee, SY Jo, JH Oh, A Lee, B Lee, SJ Jang, YA Suh Anticancer Research 40 (1), 109-119, 2020 | 1 | 2020 |
| Repurposing Metabolic Inhibitors in the Treatment of Colon Adenocarcinoma Patient-Derived Models B Lee, CH Lee, HM Moon, SY Jo, SJ Jang, YA Suh Cells 12 (24), 2859, 2023 | | 2023 |
| A robust benchmark for evaluating and improving mosaic variant calling strategies YJ Ha, J Kim, S Kang, J Kim, SY Jo, S Kim | | 2022 |
| Correction: PPARγ sumoylation-mediated lipid accumulation in lung cancer ANH Phan, VTA Vo, TNM Hua, MK Kim, SY Jo, JW Choi, HW Kim, J Son, ... Oncotarget 10 (14), 1473, 2019 | | 2019 |
| The effect of anticancer chemotherapeutics on immune microenvironment of lung adenocarcinoma with EGFR mutation in vivomicroenvironment of lung adenocarcinoma with EGFR … YA Suh, H Mun, SH Lee, SY Jo, JH Oh, CH Lee Cancer Research 78 (13_Supplement), 887-887, 2018 | | 2018 |
| Abstract A22: Cell growth regulation of gain-of-function mutant p53 via miRNAs on metabolic inhibition SY Jo, HM Moon, CH Lee, SJ Jang, YA Suh Cancer Research 76 (2_Supplement), A22-A22, 2016 | | 2016 |
| AMP-activated protein kinase (AMPK) signaling in the context of gain-of-function mutant p53 in vivo SY Jo, HM Moon, CH Lee, SJ Jang, YA Suh Cancer Research 75 (15_Supplement), 2295-2295, 2015 | | 2015 |
| Depletion of Gain-of-Function p53 Significantly Reduces the Tumor Cell Growth M Hae-Min, JC Lim, JO Se-Young, OH Ju-Hee, SUH Young-Ah 추계총회 및 학술대회 2014 (1), 282-282, 2014 | | 2014 |
